Emergence of spatial structure in the tumor microenvironment due to the Warburg effect

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 48, 2013, Pages 19402-19407

  Carmona Fontaine, Carlos ^a   Bucci, Vanni ^a   Akkari, Leila ^a   Deforet, Maxime ^a   Joyce, Johanna A ^a   Xavier, Joao B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Image analysis; Mathematical model; Tumor adaptation

Indexed keywords

LACTIC ACID;

ARTICLE; CANCER CELL; CELL METABOLISM; CELL STRUCTURE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; PREDICTION; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; WARBURG EFFECT;

IMAGE ANALYSIS; MATHEMATICAL MODEL; TUMOR ADAPTATION;

CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; IMAGE PROCESSING, COMPUTER-ASSISTED; MACROPHAGES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEOPLASMS; STATISTICS, NONPARAMETRIC; TUMOR MICROENVIRONMENT;

EID: 84888311642     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311939110     Document Type: Article

References (58)

1. Warburg O (1956) On the origin of cancer cells. Science 123(3191): 309-314.
2. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11): 891-899.
3. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1): 11-20.
4. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930): 1029-1033.
5. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5): 325-337.
6. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2): 85-95.
7. Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27: 441-464.
8. Wellen KE, Thompson CB (2012) A two-way street: Reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 13(4): 270-276.
9. Ward PS, Thompson CB (2012) Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell 21(3): 297-308.
10. San Martín A, et al. (2013) A genetically encoded FRET lactate sensor and its use to detect the Warburg effect in single cancer cells. PLoS ONE 8(2):e57712.
11. Zhang J, Nuebel E, Daley GQ, Koehler CM, Teitell MA (2012) Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11(5): 589-595.
12. Wang R, et al. (2011) The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35(6): 871-882.
13. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15(4): 300-308.
14. Lee EY, et al. (2009) Hypoxia-enhanced wound-healing function of adipose-derived stem cells: Increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17(4): 540-547.
15. Helmlinger G, Yuan F, Dellian M, Jain RK (1997) Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat Med 3(2): 177-182.
16. Gatenby RA, et al. (2007) Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 97(5): 646-653.
17. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194(4260): 23-28.
18. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6(12): 924-935.
19. Gatenby RA, Gawlinski ET (1996) A reaction-diffusion model of cancer invasion. Cancer Res 56(24): 5745-5753.
20. Anderson AR, Weaver AM, Cummings PT, Quaranta V (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127(5): 905-915.
21. Gatenby RA, Gillies RJ (2008) A microenvironmental model of carcinogenesis. Nat Rev Cancer 8(1): 56-61.
22. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203): 436-444.
23. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4): 239-252.
24. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1): 39-51.
25. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196(3): 254-265.
26. Zhang QW, et al. (2012) Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. PLoS ONE 7(12):e50946.
27. Cramer T, et al. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112(5): 645-657.
28. Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104(8): 2224-2234.
29. White C, et al. (2009) Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci 122(Pt 9): 1315-1321.
30. Gocheva V, et al. (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24(3): 241-255.
31. Wyckoff JB, et al. (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67(6): 2649-2656.
32. Ren G, et al. (2012) CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell 11(6): 812-824.
33. Gil-Bernabé AM, et al. (2012) Recruitment of monocytes/macrophages by tissue factor- mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119(13): 3164-3175.
34. Ahn GO, et al. (2010) Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 107(18): 8363-8368.
35. Goswami S, et al. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65(12): 5278-5283.
36. DeBerardinis RJ, et al. (2007) Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104(49): 19345-19350.
37. Brizel DM, et al. (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51(2): 349-353.
38. Walenta S, et al. (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60(4): 916-921.
39. Xavier JB, Picioreanu C, van Loosdrecht MCM (2005) A framework for multidimensional modelling of activity and structure of multispecies biofilms. Environ Microbiol 7(8): 1085-1103.
40. Nadell CD, Foster KR, Xavier JB (2010) Emergence of spatial structure in cell groups and the evolution of cooperation. PLOS Comput Biol 6(3):e1000716.
41. Peirce SM, Van Gieson EJ, Skalak TC (2004) Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J 18(6): 731-733.
42. Thomlinson RH, Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9(4): 539-549.
43. Swanson KR, et al. (2011) Quantifying the role of angiogenesis in malignant progression of gliomas: In silico modeling integrates imaging and histology. Cancer Res 71(24): 7366-7375.
44. Hawkins-Daarud A, Rockne RC, Anderson ARA, Swanson KR (2013) Modeling tumorassociated edema in gliomas during anti-angiogenic therapy and its impact on imageable tumor. Front Oncol 3:66.
45. Cochran DM, Fukumura D, Ancukiewicz M, Carmeliet P, Jain RK (2006) Evolution of oxygen and glucose concentration profiles in a tissue-mimetic culture system of embryonic stem cells. Ann Biomed Eng 34(8): 1247-1258.
46. Brader P, et al. (2007) Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Mol Cancer Ther 6(11): 2900-2908.
47. Cox ME, Dunn B (1986) Oxygen diffusion in poly(dimethyl siloxane) using fluorescence quenching. I. Measurement technique and analysis. J Polym Sci A Polym Chem 24: 621-636.
48. Rello S, et al. (2005) Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 10(1): 201-208.
49. Rejniak KA, Anderson ARA (2012) State of the art in computational modelling of cancer. Math Med Biol 29(1): 1-2.
50. Serganova I, et al. (2011) Metabolic imaging: A link between lactate dehydrogenase A, lactate, and tumor phenotype. Clin Cancer Res 17(19): 6250-6261.
51. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 7(9): 678-689.
52. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13(7): 265-270.
53. Hanahan D, Coussens LM (2012) Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3): 309-322.
54. Robinson BD, et al. (2009) Tumor microenvironment of metastasis in human breast carcinoma: A potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15(7): 2433-2441.
55. Fischer K, et al. (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9): 3812-3819.
56. Calcinotto A, et al. (2012) Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res 72(11): 2746-2756.
57. Pàez-Ribes M, et al. (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15(3): 220-231.
58. Ebos JML, et al. (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15(3): 232-239.